Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2015
Total Assets: $2.50B
Liabilities Breakdown FY2015
Total Liabilities: $1.40B
Asset Breakdown
Total Assets: $2.50B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $714.8M | 28.6% |
| Accounts Receivable | $173.8M | 7.0% |
| Inventory | $57.2M | 2.3% |
| Property, Plant & Equipment | $697.7M | 27.9% |
| Goodwill | $50.4M | 2.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $804.7M | 32.2% |
Liabilities Breakdown
Total Liabilities: $1.40B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $74.9M | 5.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.33B | 94.7% |